enkephalin, leucine has been researched along with buprenorphine in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (25.00) | 18.7374 |
1990's | 10 (62.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (6.25) | 24.3611 |
2020's | 1 (6.25) | 2.80 |
Authors | Studies |
---|---|
Brown, B; Dettmar, PW; Dobson, PR; Lynn, AG; Metcalf, G; Morgan, BA | 1 |
Blurton, PA; Broadhurst, AM; Wood, MD; Wyllie, MG | 1 |
Olley, JE; Tiong, GK | 1 |
Richard, JW; Sanschagrin, D; Thakur, M; Wood, PL | 1 |
Barg, J; Belcheva, MM; Coscia, CJ; Dawn, S; Ho, MT; Ignatova, E; McHale, RJ | 1 |
Barg, J; Belcheva, MM; Coscia, CJ; Ho, MT; Ignatova, EG; Jefcoat, LB; Johnson, FE; McHale, RJ; Vogel, Z | 1 |
Hall, TJ; Jagher, B; Schaeublin, M; Wiesenberg, I | 1 |
Blake, AD; Bot, G; Freeman, JC; Reisine, T | 1 |
Peter, Y; Pick, CG; Schreiber, S; Weizman, R | 1 |
Blake, AD; Bot, G; Li, S; Reisine, T | 1 |
Calderon, SN; Krassnig, R; Lai, J; Matecka, D; Ni, Q; Partilla, JS; Porreca, F; Rice, KC; Rothman, RB; Schmidhammer, H; Xu, H | 1 |
Barron, S; Belcheva, MM; Bohn, LM; Coscia, CJ; Ho, MT; Johnson, FE; Yanai, J | 1 |
Emorine, LJ; Exner, T; Gaibelet, G; Liaubet, L; Masson, JM; Meilhoc, E; Nürnberg, B; Riond, J; Saves, I | 1 |
Belkaï, E; Courtin, C; Crété, D; Marie-Claire, C; Noble, F | 1 |
Graham, DP; Hamon, SC; Hillhouse, M; Kosten, TR; Lawson, WB; Ling, W; Nielsen, DA; Nielsen, EM; Rotrosen, J; Saxon, AJ; Settles-Reaves, BD; Shmueli-Blumberg, D; Shores-Wilson, K; Trivedi, MH; Walker, R | 1 |
Adapa, ID; Auh, JS; Berzetei-Gurske, IP; Brandt, SR; Craymer, K; Farrington, L; Haggart, D; Kennedy, JM; O'Brien, A; Polgar, WE; Rodriguez, L; Schwartz, RW; Toll, L; White, A | 1 |
1 trial(s) available for enkephalin, leucine and buprenorphine
Article | Year |
---|---|
Moderation of buprenorphine therapy for cocaine dependence efficacy by variation of the Prodynorphin gene.
Topics: Buprenorphine; Buprenorphine, Naloxone Drug Combination; Cocaine; Cocaine-Related Disorders; Delayed-Action Preparations; Enkephalins; Humans; Injections, Intramuscular; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Protein Precursors | 2022 |
15 other study(ies) available for enkephalin, leucine and buprenorphine
Article | Year |
---|---|
Opiate analgesics: the effect of agonist-antagonist character on prolactin secretion.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Cyclazocine; Enkephalins; Male; Morphine; Naloxone; Narcotic Antagonists; Prolactin; Rats | 1978 |
Is there a common, high-affinity opioid binding site in rat brain?
Topics: Animals; Binding, Competitive; Brain Chemistry; Buprenorphine; Dihydromorphine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Enkephalins; Male; Naloxone; Pentazocine; Protein Binding; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, mu | 1986 |
Effects of exposure in utero to methadone and buprenorphine on enkephalin levels in the developing rat brain.
Topics: Animals; Brain; Buprenorphine; Dose-Response Relationship, Drug; Enkephalins; Female; Methadone; Pregnancy; Prenatal Exposure Delayed Effects; Rats | 1988 |
Multiple opiate receptor affinities of kappa and agonist/antagonist analgesics: in vivo assessment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analgesia; Animals; Buprenorphine; Butorphanol; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Male; Rats; Rats, Inbred Strains; Receptors, Opioid; Stereoisomerism; Substrate Specificity | 1983 |
Transient down-regulation of neonatal rat brain mu-opioid receptors upon in utero exposure to buprenorphine.
Topics: Analgesics; Animals; Animals, Newborn; Benzeneacetamides; Brain Chemistry; Buprenorphine; Down-Regulation; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Female; Membranes; Pregnancy; Prenatal Exposure Delayed Effects; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1994 |
Buprenorphine differentially alters opioid receptor adaptation in rat brain regions.
Topics: Adaptation, Physiological; Analgesics; Animals; Brain; Buprenorphine; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Kinetics; Male; Oligopeptides; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Opioid | 1996 |
The analgesic drug buprenorphine inhibits osteoclastic bone resorption in vitro, but is proinflammatory in rat adjuvant arthritis.
Topics: Analgesics; Analgesics, Opioid; Animals; Arthritis, Experimental; Arthrography; Bone Resorption; Buprenorphine; Cells, Cultured; Disease Models, Animal; Edema; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Femur; Lethal Dose 50; Naloxone; Narcotic Antagonists; Osteoclasts; Rats | 1996 |
Differential opioid agonist regulation of the mouse mu opioid receptor.
Topics: Adenylate Cyclase Toxin; Analgesics; Animals; Buprenorphine; Colforsin; Cyclic AMP; Diprenorphine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Etorphine; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Levorphanol; Methadone; Mice; Morphine; Pertussis Toxin; Receptors, Opioid, mu; Virulence Factors, Bordetella | 1997 |
Pharmacological characterization of buprenorphine, a mixed agonist-antagonist with kappa 3 analgesia.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Analgesics, Opioid; Animals; Buprenorphine; Drug Interactions; Drug Tolerance; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Male; Mice; Mice, Inbred ICR; Morphine; Naloxone; Narcotic Antagonists; Pyrrolidines; Receptors, Opioid, delta; Receptors, Opioid, kappa; Sensitivity and Specificity | 1997 |
Mutagenesis of the mouse delta opioid receptor converts (-)-buprenorphine from a partial agonist to an antagonist.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Cells, Cultured; Cyclic AMP; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Mice; Mutagenesis; Naltrexone; Narcotic Antagonists; Receptors, Opioid, delta | 1998 |
Opioid peptide receptor studies. 9. Identification of a novel non-mu- non-delta-like opioid peptide binding site in rat brain.
Topics: Analgesics, Opioid; Animals; Binding Sites; Brain; Brain Chemistry; Buprenorphine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Leucine-2-Alanine; Enkephalins; Ligands; Oligonucleotides, Antisense; Protein Binding; Rats; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1998 |
Brain opioid receptor adaptation and expression after prenatal exposure to buprenorphine.
Topics: Adaptation, Physiological; Animals; Animals, Newborn; beta-Endorphin; Brain; Buprenorphine; Cross-Linking Reagents; Down-Regulation; Electrophoresis, Polyacrylamide Gel; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Female; Narcotic Antagonists; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Receptors, Opioid; Receptors, Opioid, mu; Reverse Transcriptase Polymerase Chain Reaction | 1998 |
Nonselective coupling of the human mu-opioid receptor to multiple inhibitory G-protein isoforms.
Topics: Binding Sites; Binding, Competitive; Buprenorphine; Diprenorphine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Etorphine; Gene Expression; GTP-Binding Proteins; Guanylyl Imidodiphosphate; Humans; Protein Binding; Protein Isoforms; Receptors, Opioid, mu; Recombinant Proteins; Saccharomyces cerevisiae; Spheroplasts; Transformation, Genetic | 1999 |
Comparison of the transcriptional responses induced by acute morphine, methadone and buprenorphine.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Buprenorphine; Enkephalins; Male; Methadone; Morphine; Neostriatum; Nociceptin Receptor; Nucleus Accumbens; Pro-Opiomelanocortin; Protein Precursors; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Opioid; RNA, Messenger; Thalamus; Transcription, Genetic | 2013 |
Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications.
Topics: Animals; Aorta, Thoracic; Cocaine; Cyclic AMP; Electric Stimulation; Guinea Pigs; Humans; Ileum; In Vitro Techniques; Male; Mice; Muscle, Smooth; Opioid-Related Disorders; Rats; Receptors, Dopamine; Receptors, Opioid; Receptors, Serotonin; Substance-Related Disorders | 1998 |